Skip to main content
Caplight Logo









OrthoRebirth Co., Ltd.

OrthoRebirth Co., Ltd.

Private
YokohamaHealthcare & Life Scienceshttps://orthorebirth.com/

Last Round

Private Placement

May 12, 2026

Est. Valuation

$14.12M

Total Funding Raised

$6.28M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OrthoRebirth Co., Ltd. is a medical device company that specializes in regenerative medicine and the development of synthetic bone-void-filling materials.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bone void fillerbioresorbable scaffoldregenerative medicinesynthetic bone graftorthopedic biomaterialsbone regenerationmicrofiber scaffoldbone graft substitutemedical device manufacturertissue engineeringbiotechorthopedic surgerybone defect repairstem cell substrate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrthoRebirth Co., Ltd. Comparables

Compare OrthoRebirth Co., Ltd. with similar companies based on industry and business-model similarity.

OrthoRebirth Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stryker Corporation
78%
Cerapedics
78%
Bone Biologics Corporation
78%

OrthoRebirth Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMay 12, 2026
Early FundingOct 31, 2025
Series BMar 28, 2024
StrategicApr 30, 2019
StrategicMar 12, 2018
VC Round
Dec 28, 2017

Key People

Founding team and executive leadership

Doris Blake

President and COO

Executive Team

OrthoRebirth Co., Ltd. Investors

Notable investors and investment history

OrthoRebirth Co., Ltd. investors
InvestorRounds
Fiducia Inc.VC Round
Innovation Engine Inc.Series A
Yasuda Enterprise DevelopmentSeries A
DCI PartnersVC Round
QB CapitalVC Round
Aichi Capital Co., Ltd.Private Placement
Mitsubishi UFJ CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    $1.4M round from Aichi Capital and The Aichi Bank

  • Oct 31, 2025

    Raised capital from Hirogin Capital Partners, SIIF Impact Capital, and others.

OrthoRebirth Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

OrthoRebirth Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersYokohama
Employee Range4
Year Founded2011
Last FundingMay 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?